Cancer immunotherapy had revolutionized the field of oncology, providing noveltherapeutic options for cancer patients with dramatically improved outcomes. However, the development of the new field of ...

New immuno-oncology agents are providing durable survival for some patients, but the cost of these treatments is very high, which is a cause for concern. In a new study in JAMA Oncology, researchers ...

Tavros Therapeutics Inc. and Vividion Therapeutics Inc., a subsidiary of Bayer AG, have entered into a collaboration agreement to discover or target four oncology targets across an initial 5-year term ...

Classifying Tumor Reportability Status From Unstructured Electronic Pathology Reports Using Language Models in a Population-Based Cancer Registry Setting A retrospective study was conducted using four ...